LIFECORE BIOMEDICAL INC DE
For the period ended May 25, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Aug 7, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
As of May 25, 2025, the Company owned or leased the following principal physical properties:
| Location | Ownership | Facilities |
|---|---|---|
| Chaska, MN | Owned | 148,200 square feet of office, laboratory and manufacturing space |
| Chaska, MN | Leased | 80,950 square feet of office, manufacturing and warehouse space |
| Chanhassen, MN | Leased | 21,384 square feet of warehouse and office space |
Leases for the facilities in Chaska and Chanhassen expire on September 2034 and March 2033, respectively. For additional information about lease terms, see “Part IV, Item 15. Note 16– Leases” of this Annual Report on Form 10-K.
Our owned real property is subject to a mortgage in favor of the lenders under our revolving credit agreement, as amended, with BMO as administrative agent.
The Company does not anticipate experiencing significant difficulty in retaining occupancy of any of our manufacturing, laboratory, or office facilities through lease renewals prior to expiration or through month-to-month occupancy, or in replacing them with equivalent facilities. We believe our existing facilities, both owned and leased, are in good condition and suitable for the conduct of our business.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.